Medicine & Healthcare

News

26 May 2020
Scratching the head or rubbing the hands repeatedly is common, unconscious behaviour when people are facing stress. Neuroscientists from the School of Biomedical Sciences and the Gerald Choa Neuroscience Centre of the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) have discovered a mammalian brain circuitry underlying our ability to generate adaptive responses when facing stress with strong negative emotions. The result of the study was recently published in the renowned international scientific journal Nature Communications.
26 May 2020
The weak performance of Hong Kong children in age-appropriate tests of theory of mind (ToM) has been well documented. The awareness of mental states, such as the thoughts, wants, motives and feelings of others, and the realisation that these may differ from our own are vital for social interaction and can affect learning. Therefore, the delay in acquiring this social-cognitive skill is worrying and raises questions: What are the factors that affect the pace of reaching these developmental milestones, and can children catch up?
22 May 2020
Researchers from the School of Life Sciences at The Chinese University of Hong Kong (CUHK) and Japanese research teams have constructed a high-resolution chromosome-scale full genome sequence assembly of an American Shorthair domestic cat (AnAms1.0). By incorporating data from multiple advanced genomic technologies, this genome assembly has a much improved quality over the currently available reference. This research will drive forward precision veterinary medicine to provide the most suitable treatments based on individual differences predicted from genomic information.
20 May 2020
Research into how the SARS-CoV-2 virus induces death is suggesting potential treatments for its most destructive complications.
19 May 2020
New data on East Asian populations will guide researchers and clinicians to develop novel therapeutic strategies tailored to individual lung cancer patients.
19 May 2020
A recent study conducted by the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) discovered a novel genetic biomarker which can predict the survival of head and neck cancer patients. There are over 0.7 million new head and neck squamous cell carcinoma (HNSCC) cases globally each year. However, currently there is no clinical implementation of any genetic biomarker to predict outcomes for these patients after standard treatment. A study led by Professor Vivian Wai Yan LUI, an expert in genomic medicine and Associate Professor of the School of Biomedical Sciences at CU Medicine, and her research team, has identified that mitogen activated protein kinase (MAPK) pathway mutations found in almost 20% of HNSCC patients can predict favourable clinical outcomes with standard therapy. Their survival also doubled when compared with other patients. The finding has just been published in the journal Life Science Alliance.
19 May 2020
Scientists from Hong Kong Baptist University (HKBU) have developed a novel technique that can produce pure therapeutic drugs without the associated side effects.
19 May 2020
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.
18 May 2020
Professor Tony MOK from the Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine) and Professor LU You from West China School of Medicine at The Sichuan University co-led the world’s first-in-human Phase I clinical trial investigating the safety and feasibility of CRISPR gene-edit therapy as a treatment option for patients with late stage lung cancer. Research team recruited 22 advanced Non-small-cell lung carcinoma (NSCLC) patients and isolate the T cell (a form of white blood cell) from peripheral blood. After gene-editing by CRISPR, the T cells that were reinfused back to patient may have the ability to attack cancer cell. Objective of the study is to demonstrate safety and feasibility. Results demonstrated CRISPR technology is safe and feasible as patients showed no severe adverse events and the frequency of off-target events was only 0.05%. This opens a new chapter in the history of lung cancer immunotherapy. The findings were recently published on-line in the international medical journal Nature Medicine.
16 May 2020
Thursday, 21 May 2020, 4:00 PM (GMT +8)
cPass™
15 May 2020
As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficacy of different vaccine candidates.
15 May 2020
Japanese 'bone engineers' have developed a bone-substitute biomaterial used in dental grafts that reduces the need for harvesting bone from the patient's own body.
15 May 2020
The newly developed rapid testing kit detects COVID-19 antibodies, requiring only micro-liter volume of serum and 15 minutes of time for achieving results.
CityU’s 3T MRI animal scanner
13 May 2020
Diagnosis of Alzheimer's disease, the most common type of dementia, is not easy for its overlapping signs with normal ageing. A collaborative research by City University of Hong Kong (CityU) and Johns Hopkins University has developed a new non-invasive molecular imaging approach based on Magnetic Resonance Imaging (MRI) to dynamically measure glucose level changes in the brain lymphatic system. Their discovery may help in identifying Alzheimer's disease at early stages so that treatments can start as soon as possible.
 (From left) Dr Lung Hong Lok, Dr Jiang Lijun, Professor Gary Wong Ka-Leung and Professor Mak Nai-Ki developed a novel drug for the treatment of EBV-related cancers such as nasopharyngeal cancer.
11 May 2020
A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumours caused by the virus. It is the first known agent to successfully target the virus and disturb its latency in tumour cells in this way.
08 May 2020
When the master regulator of protein production malfunctions, it may contribute to the development of neuronal diseases such as Alzheimer's and Huntington's.
30 Apr 2020
A study presenting evidence for the presence of SARS-CoV-2 RNA in the air is published in Nature.
30 Apr 2020
The UK today confirmed that it will be the largest supporter of the international alliance to vaccinate children against deadly diseases, saving millions of lives.
30 Apr 2020
Nationwide mobile phone data tracking aggregated movements of people in China can accurately predict the geographical and temporal spread of COVID-19 infections up to two weeks ahead of time, according to a study in Nature.
29 Apr 2020
COVID-19 is affecting every corner of the world with its disastrous damage to human health and economy. Hidden infections that skip the usual surveillance system pose an obstacle to controlling the spread of COVID-19. There is currently no information on hidden COVID-19 infection in Hong Kong.
23 Apr 2020
A range of essential textbooks from all disciplines will be freely available to support higher education institutions worldwide
21 Apr 2020
Springer Nature achieves new milestone in 2019 in publishing over 100,000 OA articles in one year, and is the largest OA publisher of primary research
21 Apr 2020
It is no secret that genetic factors play a role in determining whether children have neurodevelopmental disorders. Maternal exposure to drugs and viral or bacterial illnesses can be detrimental too.
16 Apr 2020
According to a clinical study conducted by the School of Chinese Medicine (SCM) at Hong Kong Baptist University (HKBU), nearly 90% of the patients who took a six-week course of Chinese medicine formula for the treatment of “cold type” asthma had their asthma symptoms eliminated or relieved. Among this group of patients, over half had their symptoms eliminated, while 35% had their symptoms relieved or significantly relieved.
13 Apr 2020
The best timing for endoscopy of patients with acute upper gastrointestinal bleeding is still controversial among the medical community. A recent study conducted by the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) found that for patients with overt signs of acute upper gastrointestinal bleeding, urgent endoscopy performed within 6 hours after gastroenterological consultation was not associated with lower mortality and risk of further bleeding, compared with endoscopy performed between 6 and 24 hours after consultation. In other words, earlier endoscopy did not lower mortality nor improve outcomes. The study results have just been published in the top medical journal, The New England Journal of Medicine (NEJM).
07 Apr 2020
New understandings of how lipids function within tears could lead to better drugs for treating dry eye disease.
31 Mar 2020
New findings show that the formation of amyloid plaques drives damage and tissue loss in the brain during Alzheimer’s disease in animals, but lithium reduces the life-shortening effects of this loss.
31 Mar 2020
Exercise and a cell-aging drug could help cases of chronic myopathy.
31 Mar 2020
A new X-ray imaging technique could identify lesions and tumors before ultrasound or MRI can.
30 Mar 2020
Looking for experts to who can comment on the coronavirus pandemic? Our Focus On: Coronavirus resource connects journalists with experts prepared to speak with international media about different aspects of the pandemic, including public health, virology, economic impacts, travel and spread of information.

Events

Sorry, nothing coming up for this discipline

Researchers

Sorry, nothing coming up for this discipline